Home › Heart Attack › Ohio
Heart Attack clinical trials in Ohio
5 studies for Heart Attack are looking for participants at sites in Ohio.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- HNC Dialysis, Ltd., Columbus
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Akron Hospital Summa Health System, Akron
- Aultman Hospital, Canton
- Cleveland Clinic Foundation, Cleveland
- and 1 more
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Aultman Cardiology Clinical Trials, Canton
- The Christ Hospital, Cincinnati
- Velocity Clinical Research - Cincinnati, Cincinnati
- and 2 more
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Ohio State University Wexner Medical Center, Columbus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT04774159Vascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study
- Cleveland Clinic Foundation Fairview Campus, Cleveland
- Cleveland Clinic Foundation Main Campus, Cleveland
RecruitingObservational study
Ages 45 and older · All sexes · Updated Mar 19, 2026 · NCT04973397From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.